IRCT20200509047373N2招募中3 期
Effect of new trial drug on improving of clinical and paraclinical symptoms in patients ICU with COVID-19
Health Medicine Chemistry Company0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15 years 至 no limit（—）
- 性别
- All
入选标准
- •Having definite COVID-19 disease and get hospitalized
- •Age over 15 years
- •Obtaining informed consent to participate in the trial
- •Non-participation in another clinical trial simultaneously
- •Patients admitted to IC
排除标准
- •Diagnosis of the disease just based on physician diagnosis
- •Pregnancy (according to the patient's statement and examination by a physician)
- •Breastfeeding (according to the patient's statement)
研究者
相似试验
招募中
不适用
Clinical pharmacy services to improve management outcomes of Chronic Kidney Disease of uncertain etiology patients undergoing hemodialysisChronic Kidney Disease of uncertain etiologySLCTR/2018/011ational Science Foundation
已完成
2 期
Kohl Al-Ethmed in treatment of inflammation of the eyelid.IRCT201208017219N4Vice chancellor for research, Kerman University of Medical Sciences32
已完成
不适用
Clinical Study On Effectiveness Of Newly developed Radiation Diagnostic Apparatus Si/CdTe Compton CameraHealthy personJPRN-UMIN000014452Gunma University Hospital5
尚未招募
不适用
Study on the improvement of therapeutic efficacy of Staphylococcus aureus bacteremiaCertain infectious and parasitic diseasesKCT0008236Asan Medical Center338
尚未招募
Unknown
A pilot trial of the efficacy of a novel medical device to alleviate pain during venepuncture.ACTRN12623000693628Prudenfort Pty Ltd34